These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32232111)

  • 1. Neural reflex control of vascular inflammation.
    Caravaca AS; Centa M; Gallina AL; Tarnawski L; Olofsson PS
    Bioelectron Med; 2020; 6():3. PubMed ID: 32232111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural control of the immune system.
    Sundman E; Olofsson PS
    Adv Physiol Educ; 2014 Jun; 38(2):135-9. PubMed ID: 25039084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural Control of Inflammation: Bioelectronic Medicine in Treatment of Chronic Inflammatory Disease.
    Eberhardson M; Tarnawski L; Centa M; Olofsson PS
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31358521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters matter: modulating cytokines using nerve stimulation.
    Bonaz B
    Bioelectron Med; 2020; 6():12. PubMed ID: 32607391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases.
    Fu H; Ni M; Chen JK; Zhao T; Deng YP; Li DJ; Jiang GJ; Shen FM
    Curr Drug Targets; 2017; 18(15):1779-1784. PubMed ID: 26302792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.
    Ten Cate H; Guzik TJ; Eikelboom J; Spronk HMH
    Cardiovasc Res; 2021 Jul; 117(9):2030-2044. PubMed ID: 32931586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advancements in Bioelectronic Medicine: A Review.
    Das S; Ghosh B; Sahoo RN; Nayak AK
    Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38173212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
    Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Effective Method for Acute Vagus Nerve Stimulation in Experimental Inflammation.
    Caravaca AS; Gallina AL; Tarnawski L; Tracey KJ; Pavlov VA; Levine YA; Olofsson PS
    Front Neurosci; 2019; 13():877. PubMed ID: 31551672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis.
    Moss ME; Jaffe IZ
    Front Endocrinol (Lausanne); 2015; 6():153. PubMed ID: 26441842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction.
    Knorr M; Münzel T; Wenzel P
    Front Physiol; 2014; 5():295. PubMed ID: 25177297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex as a Biological Variable in Atherosclerosis.
    Man JJ; Beckman JA; Jaffe IZ
    Circ Res; 2020 Apr; 126(9):1297-1319. PubMed ID: 32324497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
    Bartoloni E; Alunno A; Valentini V; Luccioli F; Valentini E; La Paglia GMC; Leone MC; Cafaro G; Marcucci E; Gerli R
    Front Cardiovasc Med; 2018; 5():177. PubMed ID: 30619884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes.
    Johansen NJ; Knop FK
    Eur Heart J Cardiovasc Pharmacother; 2023 Jun; 9(4):311-317. PubMed ID: 36639124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
    Saiz LC; Gorricho J; Garjón J; Celaya MC; Muruzábal L; Malón MDM; Montoya R; López A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD010315. PubMed ID: 29020435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease.
    Hemenway G; Frishman WH
    Cardiol Rev; 2022 Mar-Apr 01; 30(2):90-99. PubMed ID: 33883451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ; Zamorano JL; Parhofer KG
    Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.